Ident. | Authors (with country if any) | Title |
---|
000036 (1990) |
U. Sabatini [France] ; O. Rascol [France] ; P. Celsis [France] ; J. P. Marc-Vergnes [France] ; J. L. Montastruc [France] | Effects of apomorphine on cerebral blood flow and extrapyramidal symptoms in Parkinson's disease |
000292 (2000) |
Jj Ferreira [France, Portugal] ; M. Galitzky [France] ; Jl Montastruc [France] ; O. Rascol [France] | Sleep attacks and Parkinson's disease treatment |
000353 (2008) |
J. C. Sharma [Royaume-Uni] ; I. N. Ross [Royaume-Uni] ; O. Rascol [France] ; D. Brooks [Royaume-Uni] | Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight |
000730 (2013) |
A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; C. Debieuvre [France] ; M. Fraessdorf [Allemagne] ; W. Poewe [Autriche] | Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease |
000855 (2013) |
A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; C. Debieuvre [France] ; M. Fraessdorf [Allemagne] ; W. Poewe [Autriche] | Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease |
000A25 (2012) |
S. Perez-Lloret [France, Argentine] ; L. Nègre-Pagès [France] ; A. Ojero-Senard [France] ; P. Damier ; A. Destée ; F. Tison [France] ; M. Merello [Argentine] ; O. Rascol [France] | Oro‐buccal symptoms (dysphagia, dysarthria, and sialorrhea) in patients with Parkinson’s disease: preliminary analysis from the French COPARK cohort |
000B34 (2013) |
J. J. Ferreira [Portugal] ; R. Katzenschlager [Autriche] ; B. R. Bloem [Pays-Bas] ; U. Bonuccelli [Italie] ; D. Burn [Royaume-Uni] ; G. Deuschl [Allemagne] ; E. Dietrichs [Norvège] ; G. Fabbrini [Italie] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; V. Kostic [Serbie] ; A. Nieuwboer [Belgique] ; P. Odin [Allemagne, Suède] ; W. Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal] ; M. Schüpbach [France, Suisse] ; E. Tolosa [Espagne] ; C. Trenkwalder [Allemagne] ; A. Schapira [Royaume-Uni] ; A. Berardelli [Italie] ; W. H. Oertel [Allemagne] | Summary of the recommendations of the EFNS/MDS‐ES review on therapeutic management of Parkinson's disease |
000D12 (1989) |
J L Montastruc [France] ; O. Rascol [France] ; A. Rascol [France] | A randomised controlled study of bromocriptine versus levodopa in previously untreated Parkinsonian patients: a 3 year follow-up. |
000F27 (1991) |
A. Agniel [France] ; P. Celsis [France] ; G. Viallard [France] ; J L Montastruc [France] ; O. Rascol [France] ; J F Demonet [France] ; J P Marc-Vergnes [France] ; A. Rascol [France] | Cognition and cerebral blood flow in lateralised parkinsonism: lack of functional lateral asymmetries. |
001165 (2007) |
A. Gerdelat-Mas [France] ; M. Simonetta-Moreau [France] ; C. Thalamas [France] ; F. Ory-Magne [France] ; T. Slaoui [France] ; O. Rascol [France] ; C. Brefel-Courbon [France] | Levodopa raises objective pain threshold in Parkinson’s disease: a RIII reflex study |
001173 (1994) |
Jl Montastruc [France] ; Me Llau [France] ; O. Rascol [France] ; Jm Senard [France] | Drug‐induced parkinsonism: a review |
001245 (2009) |
A. H. Schapira [Royaume-Uni] ; Y. Agid [France] ; P. Barone [Italie] ; P. Jenner [Royaume-Uni] ; M. R. Lemke [Allemagne] ; W. Poewe [Autriche] ; O. Rascol [France] ; H. Reichmann [Allemagne] ; E. Tolosa [Espagne] | Perspectives on recent advances in the understanding and treatment of Parkinson’s disease |
001274 (2006) |
J. J. Ferreira [Portugal] ; K. Desboeuf [France] ; M. Galitzky [France] ; C. Thalamas [France] ; C. Brefel-Courbon [France] ; N. Fabre [France] ; J. Senard [France] ; J. Montastruc [France] ; C. Sampaio [Portugal] ; O. Rascol [France] | Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson's disease: a clinical survey in PD patients and age‐matched healthy volunteers |
001303 (2006) |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; W. Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society‐European Section (MDS‐ES). Part II: late (complicated) Parkinson's disease |
001566 (2006) |
M. Horstink [Pays-Bas] ; E. Tolosa [Espagne] ; U. Bonuccelli [Italie] ; G. Deuschl [Allemagne] ; A. Friedman [Pologne] ; P. Kanovsky [République tchèque] ; J. P. Larsen [Norvège] ; A. Lees [Royaume-Uni] ; W. Oertel [Allemagne] ; W. Poewe [Autriche] ; O. Rascol [France] ; C. Sampaio [Portugal] | Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease |
001574 (2011) |
O. Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
001852 (1994) |
O. Blin [France] ; C. Desnuelle [France] ; O. Rascol [France] ; M. Borg [France] ; H. Peyro Saint Paul [France] ; J. P. Azulay [France] ; F. Billé [France] ; D. Figarella [France] ; F. Coulom [France] ; J. F. Pellissier [France] ; J. L. Montastruc [France] ; M. Chatel [France] ; G. Serratrice [France] | Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy |
002122 (1994) |
O. Rascol [France] ; U. Sabatini [France] ; F. Chollet [France] ; N. Fabre [France] ; J M Senard [France] ; J L Montastruc [France] ; P. Celsis [France] ; J P Marc-Vergnes [France] ; A. Rascol [France] | Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa. |
002225 (1994) |
J L Montastruc [France] ; O. Rascol [France] ; J M Senard [France] ; A. Rascol [France] | A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up. |
002242 (1989) |
O. Rascol [France] ; M. Clanet [France] ; J. L. Montastruc [France] ; M. Simonetta [France] ; M. J. Soulier-Esteve [France] ; B. Doyon [France] ; A. Rascol [France] | ABNORMAL OCULAR MOVEMENTS IN PARKINSON'S DISEASE |
002390 (2010) |
Suzanne Lesage ; Etienne Patin ; Christel Condroyer ; Anne-Louise Leutenegger ; Ebba Lohmann ; Nir Giladi ; Anat Bar-Shira ; Soraya Belarbi ; Nassima Hecham ; Pierre Pollak ; Anne-Marie Ouvrard-Hernandez ; Soraya Bardien ; Jonathan Carr ; Traki Benhassine ; Hiroyuki Tomiyama ; Caroline Pirkevi ; Tarik Hamadouche [Algérie] ; Ccile Cazeneuve [France] ; A. Nazli Basak ; Nobutaka Hattori ; Alexandra Drr [France] ; Meriem Tazir ; Avi Orr-Urtreger ; Lluis Quintana-Murci ; Alexis Brice [France] ; Y. Agid ; A.-M. Bonnet ; M. Borg ; A. Brice ; E. Broussolle ; Ph. Damier ; A. Deste ; A. Drr ; F. Durif ; E. Lohmann ; M. Martinez ; C. Penet ; P. Pollak ; O. Rascol ; F. Tison ; C. Tranchant ; A. Troiano ; M. Vrin ; F. Viallet ; M. Vidailhet | Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans |